191 related articles for article (PubMed ID: 30006181)
1. A high-sensitivity HPLC-ELSD method for HPMC-AS quantification and its application in elucidating the release mechanism of HPMC-AS based amorphous solid dispersions.
Wang S; Liu C; Chen Y; Zhang Z; Zhu A; Qian F
Eur J Pharm Sci; 2018 Sep; 122():303-310. PubMed ID: 30006181
[TBL] [Abstract][Full Text] [Related]
2. Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.
Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
Pharm Res; 2016 Oct; 33(10):2445-58. PubMed ID: 27283830
[TBL] [Abstract][Full Text] [Related]
3. Aggregation of Hydroxypropyl Methylcellulose Acetate Succinate under Its Dissolving pH and the Impact on Drug Supersaturation.
Wang S; Liu C; Chen Y; Zhu AD; Qian F
Mol Pharm; 2018 Oct; 15(10):4643-4653. PubMed ID: 30130968
[TBL] [Abstract][Full Text] [Related]
4. Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.
Chen Y; Liu C; Chen Z; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
Mol Pharm; 2015 Feb; 12(2):576-89. PubMed ID: 25535667
[TBL] [Abstract][Full Text] [Related]
5. Characterization of Phase Transformations for Amorphous Solid Dispersions of a Weakly Basic Drug upon Dissolution in Biorelevant Media.
Elkhabaz A; Sarkar S; Simpson GJ; Taylor LS
Pharm Res; 2019 Oct; 36(12):174. PubMed ID: 31667638
[TBL] [Abstract][Full Text] [Related]
6. Insights into the Release Mechanisms of ITZ:HPMCAS Amorphous Solid Dispersions: The Role of Drug-Rich Colloids.
Nunes PD; Pinto JF; Henriques J; Paiva AM
Mol Pharm; 2022 Jan; 19(1):51-66. PubMed ID: 34919407
[TBL] [Abstract][Full Text] [Related]
7. Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion.
Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
Mol Pharm; 2016 Aug; 13(8):2787-95. PubMed ID: 27337060
[TBL] [Abstract][Full Text] [Related]
8. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
Jackson MJ; Kestur US; Hussain MA; Taylor LS
Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
[TBL] [Abstract][Full Text] [Related]
9. Solution behavior of PVP-VA and HPMC-AS-based amorphous solid dispersions and their bioavailability implications.
Qian F; Wang J; Hartley R; Tao J; Haddadin R; Mathias N; Hussain M
Pharm Res; 2012 Oct; 29(10):2765-76. PubMed ID: 22315020
[TBL] [Abstract][Full Text] [Related]
10. Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.
Purohit HS; Taylor LS
Pharm Res; 2017 Dec; 34(12):2842-2861. PubMed ID: 28956218
[TBL] [Abstract][Full Text] [Related]
11. Combined Effects of Supersaturation Rates and Doses on the Kinetic-Solubility Profiles of Amorphous Solid Dispersions Based on Water-Insoluble Poly(2-hydroxyethyl methacrylate) Hydrogels.
Schver GCRM; Lee PI
Mol Pharm; 2018 May; 15(5):2017-2026. PubMed ID: 29601723
[TBL] [Abstract][Full Text] [Related]
12. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
Xie T; Taylor LS
Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
[TBL] [Abstract][Full Text] [Related]
13. Comparison of HPMC based polymers performance as carriers for manufacture of solid dispersions using the melt extruder.
Ghosh I; Snyder J; Vippagunta R; Alvine M; Vakil R; Tong WQ; Vippagunta S
Int J Pharm; 2011 Oct; 419(1-2):12-9. PubMed ID: 21782911
[TBL] [Abstract][Full Text] [Related]
14. Site specific solubility improvement using solid dispersions of HPMC-AS/HPC SSL--mixtures.
Zecevic DE; Meier R; Daniels R; Wagner KG
Eur J Pharm Biopharm; 2014 Jul; 87(2):264-70. PubMed ID: 24768770
[TBL] [Abstract][Full Text] [Related]
15. Improved Release of Celecoxib from High Drug Loading Amorphous Solid Dispersions Formulated with Polyacrylic Acid and Cellulose Derivatives.
Xie T; Taylor LS
Mol Pharm; 2016 Mar; 13(3):873-84. PubMed ID: 26791934
[TBL] [Abstract][Full Text] [Related]
16. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels.
Sun DD; Ju TC; Lee PI
Eur J Pharm Biopharm; 2012 May; 81(1):149-58. PubMed ID: 22233548
[TBL] [Abstract][Full Text] [Related]
17. Does Media Choice Matter When Evaluating the Performance of Hydroxypropyl Methylcellulose Acetate Succinate-Based Amorphous Solid Dispersions?
Bapat P; Paul S; Thakral NK; Tseng YC; Taylor LS
Mol Pharm; 2023 Nov; 20(11):5714-5727. PubMed ID: 37751517
[TBL] [Abstract][Full Text] [Related]
18. Correlationship of Drug-Polymer Miscibility, Molecular Relaxation and Phase Behavior of Dipyridamole Amorphous Solid Dispersions.
Sharma J; Singh B; Agrawal AK; Bansal AK
J Pharm Sci; 2021 Apr; 110(4):1470-1479. PubMed ID: 33333143
[TBL] [Abstract][Full Text] [Related]
19. Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: A review from bench to clinic.
Butreddy A
Eur J Pharm Biopharm; 2022 Aug; 177():289-307. PubMed ID: 35872180
[TBL] [Abstract][Full Text] [Related]
20. Dissolution and precipitation behavior of amorphous solid dispersions.
Alonzo DE; Gao Y; Zhou D; Mo H; Zhang GGZ; Taylor LS
J Pharm Sci; 2011 Aug; 100(8):3316-3331. PubMed ID: 21607951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
